Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInduction Heal. Regulatory News (INHC)

Share Price Information for Induction Heal. (INHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 11.00
Ask: 14.00
Change: 0.00 (0.00%)
Spread: 3.00 (27.273%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
INHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Zesty surpasses 200k registered patients in the UK

22 Mar 2021 07:00

RNS Number : 9140S
Induction Healthcare Group PLC
22 March 2021
 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Induction Zesty surpasses 200,000 registered patients in the UK

 

Market-leading portal empowers patients to take control of their appointments, correspondence and clinical records from the convenience of their smartphone

 

Induction Healthcare (AIM: INHC), a leading virtual care platform driving digital transformation of healthcare systems worldwide, announces that its market-leading patient portal, Induction Zesty, has surpassed 200,000 patient users in the UK.

 

In March 2020, registered users of Induction Zesty had more than doubled from 32,000 to 76,000 in one year. In the subsequent 12 months, Induction Zesty saw exponential growth to reach 202,000 users today. With more than 700 new patient registrations daily, this number will continue its climb unabated, especially as hospital activity returns to pre-pandemic levels.

 

The platform serves as a digital front door for hospitals, with an intuitive interface that gives patients easy and secure access to appointment bookings, clinical letters and copies of clinical records. Additionally, at participating hospitals, Induction Zesty supports access to Apple's Health Records on iPhone.

 

Induction Zesty is employed by several NHS Trusts across the UK, including The Royal Free London NHS Foundation Trust, a Global Digital Exemplar, and Milton Keynes University Hospital NHS Trust, with whom Induction has been working for three years. Data from Milton Keynes show that 97% of patients report that Induction Zesty provides easy registration, and 85% say they prefer having online control over their appointments.

 

For more information on Induction Zesty visit: https://inductionhealthcare.com/zesty

 

James Balmain, Joint-CEO of Induction Healthcare, said: "These numbers are proof that Induction Zesty is a favoured and reliable platform. Patients appreciate the ease, convenience and accessibility of the portal, and hospitals benefit from a reduction in both time and costs - with greater staff satisfaction - when they involve patients in the management of their own care."

 

ENQUIRIES

 

Induction Healthcarehttps://inductionhealthcare.com

Dr Hugo Stephenson, Joint Chief Executive Officer

Via Walbrook PR

James Balmain, Joint Chief Executive Officer

 

 

 

N+1 Singer (Nominated Adviser and Broker)

+44 (0)20 7496 3000

Philip Davies / Kailey Aliyar

 

 

 

Walbrook PR Ltd 

+44 (0)20 7933 8780 or induction@walbrookpr.com

Paul McManus / Alice Woodings

+44 (0)7980 541 893 / +44 (0)7407 804 654

 

About Induction Healthcare - https://inductionhealthcare.com

 

Induction Healthcare (AIM: INHC) is a leading virtual care platform driving digital transformation of healthcare systems worldwide. Induction solutions enhance the investments hospital systems have made and lay the foundation for their future. Our products can enable information share between busy doctors, alleviate operational burdens on hospitals or put patients in better control of their care, all while ensuring the highest standards of clinical safety and information security. We unchain staff and patients from the limitations of paper-based and desktop systems - and that creates massive time and cost efficiencies.

 

More than 200,000 hospital doctors across multiple territories, including the UK, Ireland, Australia and South Africa, as well as a rapidly growing number of more than 200,000 UK patients, choose Induction solutions.

 

Induction Switch is the number one healthcare collaboration app in the UK, used by the majority of hospital doctors within the NHS. The app helps to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting.

 

Induction Guidance provides medical organisations, including most hospital trusts within the NHS, with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. This increases knowledge of, and adherence to, guidance.

 

Induction Zesty is a market-leading digital platform for patients visiting hospitals. The platform allows patients to book and access their appointments, read their clinical letters, store a copy of their clinical record and provide data to their care teams remotely. It is not just a compelling patient experience, but also delivers significant cost benefits to hospitals.

 

Induction HealthStream is a proprietary data integration platform that reads and writes patient demographic, appointment and clinical record data between a growing number of hospital EHR systems and the Induction platforms. This connectivity between stakeholders and legacy IT systems adds substantial value to pre-existing health IT investment and allows large-scale adoption of Induction app-based services.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAJLMITMTJBBRB
Date   Source Headline
29th Apr 20247:00 amRNSFull Year Trading Update
29th Jan 20247:00 amRNSBlock listing Interim Review
7th Nov 20237:00 amRNSHalf-year Report
10th Oct 20237:00 amRNSUpdate on NHS National Portals Contracts
31st Jul 20233:13 pmRNSBlock listing Interim Review
31st Jul 20237:00 amRNSAudited Final Results
30th Jun 20237:00 amRNSBoard Changes and Trading Update
18th Apr 20237:00 amRNSTrading Update for year ending 31 March 2023
27th Jan 20237:00 amRNSBlock Listing Six Monthly Return
17th Jan 20237:00 amRNSChange of Registered Office
16th Jan 202312:20 pmRNSDirector/PDMR Shareholding
11th Jan 202312:52 pmRNSResults of 2022 Annual General Meeting
9th Jan 20237:00 amRNSDirectorate Changes
20th Dec 20227:00 amRNSNotice of AGM
20th Dec 20227:00 amRNSChange of Auditor
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Dec 202211:05 amRNSSecond Price Monitoring Extn
5th Dec 202211:00 amRNSPrice Monitoring Extension
5th Dec 20227:01 amRNSDirectorate Changes
5th Dec 20227:00 amRNSHalf-year Report
29th Nov 202212:01 pmEQSInduction Healthcare Group focused on 'building out core capability'
28th Nov 20227:01 amRNSNotice of Half-year results
28th Nov 20227:00 amRNSAudited Final Results
24th Oct 20227:00 amRNSUpdate on publication of Audited Final Results
22nd Sep 20227:00 amRNSExtension to 2022 annual reporting deadline
27th Jul 202210:30 amRNSBlock Listing Six Monthly Return
11th Jul 20227:00 amRNSDistribution agreement for Zesty with System C
5th Jul 20227:01 amEQSEdison Investment Research Limited: Induction Healthcare Group (INHC) initiation – Evolving technology in healthcare
7th Jun 20227:00 amRNSDirectorate Change
31st May 202212:58 pmRNSHolding(s) in Company
4th May 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSTotal Voting Rights
21st Apr 20227:00 amRNSPost-period end Trading Update
13th Apr 20224:01 pmRNSHolding(s) in Company
12th Apr 20224:00 pmRNSPurchase of Shares by Director
12th Apr 202212:11 pmRNSHolding(s) in Company
12th Apr 20227:00 amRNSPurchase of Shares by Directors
11th Apr 20227:00 amRNSNHS England contract renewals secure £6.6m ARR
7th Apr 20229:27 amRNSHolding(s) in Company
4th Apr 20227:00 amRNSFour London NHS Trusts sign with Induction Zesty
30th Mar 202211:00 amRNSAIM Rule 17 Schedule 2(g) Update
21st Mar 20227:00 amRNSNHS Scotland & Scottish Govt. Contract Renewals
26th Jan 20227:00 amRNSBlock Listing Six Monthly Return
6th Dec 20217:00 amRNSInduction AA rolls out new services nationwide
2nd Dec 202112:20 pmRNSPurchase of Shares by Directors
2nd Dec 20217:00 amRNSUnaudited Interim Results
26th Nov 20217:00 amRNSNotice of Half-year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.